Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Jinxin Fertility Group's Revenue for the
six
months ended in Dec. 2025 was €165.0 Mil. Jinxin Fertility Group's average Accounts Receivable for the
six
months ended in Dec. 2025 was €20.4 Mil.
Hence, Jinxin Fertility Group's Receivables Turnover for the
six
months ended in Dec. 2025 was 8.09.
Jinxin Fertility Group (FRA:3NX) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Jinxin Fertility Group Receivables Turnover Related Terms
Jinxin Fertility Group Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Jinxin Fertility Group's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3NX vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Jinxin Fertility Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinxin Fertility Group (FRA:3NX) has a Receivables Turnover of 8.09 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Jinxin Fertility Group and its competitors. According to the industry distribution chart, Jinxin Fertility Group ranks #169 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 25.6%.
Is Jinxin Fertility Group's Receivables Turnover too high?
Jinxin Fertility Group's current Receivables Turnover is 8.09. The Healthcare Providers & Services industry median Receivables Turnover is 7.98. Jinxin Fertility Group's value of 8.09 is 1.4% above this industry median. Based on the distribution chart, Jinxin Fertility Group ranks #169 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Jinxin Fertility Group has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #169 out of 659 companies for Receivables Turnover. This puts Jinxin Fertility Group in the upper half of its industry. The industry median Receivables Turnover is 7.98. Jinxin Fertility Group's value of 8.09 is 1.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.98, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinxin Fertility Group's current Receivables Turnover of 8.09 is 1.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Jinxin Fertility Group and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current Receivables Turnover is 8.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Jinxin Fertility Group (FRA:3NX) has a current Receivables Turnover of 8.09. The stock's GF Value™ is €0.39, compared to a current price of €0.23 — trading 42.1% below its estimated fair value. The current Receivables Turnover is 8.09 and 1.4% above the Healthcare Providers & Services industry median of 7.98. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Jinxin Fertility Group (FRA:3NX), the current Receivables Turnover is 8.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (FRA:3NX) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of €0.23 is trading 42.1% below its estimated GF Value™ of €0.39.
Key valuation signals for FRA:3NX:
Receivables Turnover: 8.09
GF Value™: €0.39 vs. price of €0.23 (42.1% below fair value)
Industry Position: 1.4% above the Healthcare Providers & Services median (#169 of 659)
No single metric tells the full story. See the FRA:3NX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for FRA:3NX
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3NX has been successfully added to your 
